Table 3.
Comparative ex-in vitro dissolution profile of different formulations
| Time (h) | Percentage amount of drug release |
||||||
|---|---|---|---|---|---|---|---|
| Pure drug solution | Formulation |
||||||
| NF1 | NF2 | NF3 | LF1 | LF2 | LF3 | ||
| 1 | 67.56±1.60 | 07.89 ± 0.99 | 06.37 ± 0.99 | 12.89 ± 0.99 | 6.81±0.89 | 7.89 ± 0.99 | 05.37 ± 0.93 |
| 2 | 78.31±1.10 | 13.04 ± 0.98 | 13.12 ± 0.98 | 15.68 ± 0.98 | 12.12 ± 0.45 | 13.04 ± 0.98 | 11.13 ± 0.93 |
| 3 | 78.80±1.40 | 13.36 ± 0.99 | 14.31 ± 1.09 | 18.92 ± 0.97 | 13.17 ± 0.67 | 13.36 ± 0.99 | 13.21 ± 1.10 |
| 4 | 78.98±1.30 | 14.00 ± 0.98 | 15.87 ± 1.17 | 24.76 ± 0.94 | 13.98 ± 0.28 | 14.00 ± 0.98 | 14.87 ± 0.98 |
| 5 | 80.00±1.30 | 15.64 ± 0.97 | 16.59 ± 0.99 | 27.56 ± 0.99 | 14.69 ± 0.57 | 15.64 ± 0.97 | 15.52 ± 0.56 |
| 6 | 80.64±1.25 | 17.56 ± 0.99 | 18.57 ± 0.98 | 27.89 ± 0.98 | 16.34 ± 0.78 | 17.56 ± 0.99 | 17.53 ± 0.98 |
| 7 | 81.74±1.80 | 17.76 ± 1.05 | 20.55 ± 0.99 | 28.56 ± 0.99 | 17.26 ± 0.98 | 17.76 ± 1.00 | 19.38 ± 0.78 |
| 8 | 83.12±1.30 | 18.89 ± 1.10 | 22.56 ± 0.98 | 29.81 ± 1.07 | 18.39 ± 1.05 | 18.89 ± 1.10 | 21.54 ± 0.98 |